Mersana Therapeutics Announces Appointment of Martin H. Huber, M.D., to Board of Directors

NEXT STORY
AgEagle Receives Follow-On Purchase Orders to Manufacture Commercial Drones for Package Delivery
PREV STORY
TCR² Therapeutics Announces Immuno-Oncology Pioneer Dr. Axel Hoos Joins its Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Selecta Biosciences Reports Second Quarter 2020 Financial Results and Provides Corporate Updates

author_avatar
NASDAQ Market News

Rexahn Pharmaceuticals Receives New U.S. Patent for Supinoxin™

ROCKVILLE, Md., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a ...

author_avatar
NASDAQ Market News

Idera Pharmaceuticals Presents Clinical Data from the ILLUMINATE-204 Trial of the Combination of tilsotolimod and ipilimumab for Anti-PD-1 Refractory Metastatic Melanoma at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

- Data from Ongoing Phase 2 Study to be Presented at 1:15 PM CT ...

author_avatar
NASDAQ Market News